ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $671,506 | -58.8% | 123,212 | -49.3% | 0.00% | – |
Q2 2023 | $1,629,416 | +33.4% | 242,834 | +75.6% | 0.00% | – |
Q1 2023 | $1,221,348 | -74.3% | 138,318 | -77.8% | 0.00% | -100.0% |
Q4 2022 | $4,756,313 | +612.0% | 622,554 | +563.6% | 0.00% | – |
Q3 2022 | $668,000 | -27.5% | 93,809 | -17.7% | 0.00% | – |
Q2 2022 | $922,000 | -46.3% | 113,985 | -7.9% | 0.00% | – |
Q1 2022 | $1,718,000 | -46.3% | 123,788 | +8.6% | 0.00% | – |
Q4 2021 | $3,198,000 | +17.1% | 114,000 | +41.8% | 0.00% | – |
Q3 2021 | $2,732,000 | -60.0% | 80,381 | -51.9% | 0.00% | -100.0% |
Q2 2021 | $6,823,000 | +15.5% | 166,984 | +13.8% | 0.00% | – |
Q1 2021 | $5,906,000 | -75.7% | 146,689 | -64.3% | 0.00% | -100.0% |
Q4 2020 | $24,308,000 | +117.7% | 411,104 | +79.1% | 0.00% | -33.3% |
Q3 2020 | $11,166,000 | +5.8% | 229,600 | +5.2% | 0.00% | 0.0% |
Q2 2020 | $10,556,000 | +38.3% | 218,173 | -20.6% | 0.00% | +50.0% |
Q1 2020 | $7,632,000 | +11.7% | 274,726 | +20.3% | 0.00% | 0.0% |
Q4 2019 | $6,832,000 | +15.9% | 228,321 | +19.7% | 0.00% | 0.0% |
Q3 2019 | $5,893,000 | – | 190,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |